Traditional Chinese Simplified Chinese Email this article
Recall of four batches of Cinnarizine Tablet 25mg (with photo)

     The Department of Health (DH) today (March 22) endorsed a licensed drug wholesaler, Star Medical Supplies Ltd, to recall four batches of Cinnarizine Tablet 25mg (registration number: HK-12005) (batch numbers: M40594/1, M40594/2, 150282/1 and 150282/2) from the market because of a quality issue.

     The DH received notification from Star Medical that it has received complaints about black spots found on certain cinnarizine tablets. The black spots were suspected to be foreign matter including plastic fragments and lubricant. The Italian manufacturer decided to recall four affected batches from the market after preliminary investigation. DH's investigation is continuing.

     Cinnarizine Tablet is an over-the-counter medicine used for the treatment of motion sickness, nausea and vomiting. According to Star Medical, about 1,261 bottles (each bottle containing 1,000 tablets) from the affected four batches have been supplied to the Hospital Authority, one private hospital and private doctors. Star Medical had informed the above hospitals and doctors to stop supplying the affected batches of the products to patients.

     So far, the DH has not received any adverse reports in connection with the product concerned.

     Star Medical has set up a hotline (2370 1183) to answer related enquiries. The DH will closely monitor the recall.

     People who have consumed the above product should consult their healthcare professionals when in doubt.

Ends/Tuesday, March 22, 2016
Issued at HKT 19:47


Print this page